Cost-utility analysis of the CyberKnife system for metastatic spinal tumors

Neurosurgery

Volumn 64, Issue 2 SUPPL., 2009, Pages

  Papatheofanis, Frank J ^a,b   Williams, Erin ^c   Chang, Steven D ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c The Aequitas Group Inc   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Metastases; Metastatic spinal tumors; Quality adjusted lite years; Stereotactic radiosurgery

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CYBERKNIFE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SPINE METASTASIS; SPINE TUMOR; STEREOTACTIC RADIOSURGERY;

COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RADIOSURGERY; SPINAL NEOPLASMS;

EID: 61449242727     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000341205.37067.DE     Document Type: Article

References (43)

1. Bhatnagar AK, Gerszten PC, Ozhasaglu C, Vogel WJ, Kalnicki S, Welch WC, Burton SA: CyberKnife frameless radiosurgery for the treatment of extracranial benign tumors. Technol Cancer Res Treat 4:571-576, 2005.
2. Bremer M, Rades D, Blach M, Krenkel B, Karstens JH: Effectiveness of hypofractionated radiotherapy in painful bone metastases. Two prospective studies with 1 × 4 Gy and 4 × 4 Gy. Strahlenther Onkol 175:382-386, 1999.
3. 2a. Butler JM, Rapp SR, Shaw EG: Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol 7:517-523, 2006.
4. Chow E, Fung K, Panzarella T, Bezjak A, Danjoux C, Tannock I: A predictive mode] for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 53:1291-1302, 2002.
5. Degen JW, Gagnon GJ, Voyadzis JM, McRae DA, Lunsden M, Dieterich S, Molzahn I, Henderson FC: CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine 2:540-549, 2005.
6. Delea T, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G: Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 4:341-347, 2006.
7. 5a. Dijkers MP: Quality of life of individuals with spinal cord injury: A review of conceptualization, measurement, and research findings. J of Rehabil Res Dev 42 [Suppl 1]:87-110, 2005.
8. 5b. Dooms CA, Lievens YN, Vansteenkiste JF: Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer. Eur Respir J 27:895-901, 2006.
9. 5c. Dranitsaris G, Hsu T: Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer. Support Care Cancer 7:271-279, 1999.
10. Falkmer U, Järhult J, Wersäll P, Cavallin-Ståhl E: A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 42:620-633, 2003.
11. Gagnon GJ, Henderson FC, Gehan EA, Sanford D, Collins BT, Moulds JC, Dritschilo A: CyberKnife radiosurgery for breast cancer spine metastases: A matched-pair analysis. Cancer 110:1796-1802, 2007.
12. Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, Howard GC, Rodger A: Pain relief and quality of life following radiotherapy for bone metastases: A randomised trial of two fractionation schedules. Radiother Oncol 45:109-116, 1997.
13. Gerszten PC, Burton SA, Belani CP, Ramalingam S, Friedland DM, Ozhasoglu C, Quinn AE, McCue KJ, Welch WC: Radiosurgery for the treatment of spinal lung metastases. Cancer 107:2653-2661, 2006.
14. Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, Friedland DM: Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 3:288-295, 2005.
15. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC: Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution. Spine 32:193-199, 2007.
16. Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM: Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg 83:213-221, 2005.
17. Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, Vogel WJ: Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer 104:2244-2254, 2005.
18. Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ: Combination kyphoplasty and spinal radiosurgery: A new treatment paradigm for pathological fractures: J Neurosurg Spine 3:296-301, 2005.
19. Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC: CyberKnife frameless single-fraction stereotactic radiosurgery for benign tumors of the spine. Neurosurg Focus 14: el6, 2003.
20. Gerszten PC, Ozhasoglu C, Burton SA, Vogel W, Atkins B, Kalnicki S, Welch WC: Evaluation of CyberKnife frameless real-time image-guided stereotactic radiosurgery for spinal lesions. Stereotact Funct Neurosurg 81:84-89, 2003.
21. Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC: CyberKnife frameless stereotactic radiosurgery for spinal lesions: Clinical experience in 125 cases. Neurosurgery 55:89-99, 2004.
22. Gerszten PC, Ozhasoglu C, Burton SA, Welch WC, Vogel WJ, Atkins BA, Kalnicki S: CyberKnife frameless single-fraction stereotactic radiosurgery for tumors of the sacrum. Neurosurg Focus 15:e7, 2003.
23. Gibbs IC: Frameless image-guided intracranial and extracranial radiosurgery using the CyberKnife robotic system. Cancer Radiother 10:283-287, 2006.
24. Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR: Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36:311-319, 1995.
25. 20a. Hillner BE, Weeks JC, Desch CE, Smith TJ: Pamidronate in prevention of bone complications in metastatic breast cancer: A cost-effectiveness analysis. J Clin Oncol 18:72-79, 2000.
26. Huguenin PU, Kieser S, Glanzmann C, Capaul R, Liitolf UM: Radiotherapy for metastatic carcinomas of the kidney or melanomas: An analysis using palliative end points. Int J Radiat Oncol Biol Phys 41:401-405, 1998.
27. 21a. Hutton J, Brown R, Borowitz M, Abrams K, Rothman M, Shakespeare A: A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer. Pharmacoeconomics 9 [Suppl 2]:8-22, 1996.
28. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42:161-167, 1998.
29. Jin JY, Chen Q, Jin R, Rock J, Anderson J, Li S, Movsas B, Ryu S: Technical and clinical experience with spine radiosurgery: A new technology for management of localized spine metastases. Technol Cancer Res Treat 6:127-133, 2007.
30. 23a. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS: Screening for prostate cancer. A decision analytic view. JAMA 272:773-780, 1994.
31. Kutikova L, Bowman L, Chang S, Long SR, Thornton DE, Crown WH: Utilization and cost of health care services associated with primary malignant rumors in the United States. J Neurooncol 81:61-65, 2007.
32. 24a. Lloyd A, Nafees B, Narewska J, Dewilde S, Watkins J: Health state utilities for metastatic breast cancer. Br J Cancer 95:683-690, 2006.
33. 24b. Mooney G, Jan S: A second opinion. Cost-utility analysis and varying preferences for health. Health Policy 41:201-205, 1997.
34. National Comprehensive Cancer Network: Central nervous system cancers, in Clinical Practice Guidelines in Oncology, 2006, vol 2. http://www.nccn.org. Accessed 12/20/06.
35. Neumann PJ, Rosen AB, Weinstein MC: Medicare and cost-effectiveness analysis. N Engl J Med 353:1516-1522, 2005.
36. Niewald M, Tkocz HL Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M: Rapid course radiation therapy vs. more standard treatment: A randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 36:1085-1089, 1996.
37. Penrod JD, Deb P, Luhrs C, Dellenbaugh C, Zhu CW, Hochman T, Maciejewski ML, Granieri E, Morrison RS: Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med 9:855-860, 2006.
38. Rock JP, Ryu S, Yin FF, Schreiber F, Abdulhak M: The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors. J Neurooncol 69:319-334, 2004.
39. Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, Adler JR Jr: Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery 49:838-846, 2001.
40. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Warlam-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E, Leer J, van Mierlo T: The effect of a single fraction compared to multiple fractions on painful bone metastases: A global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101-109, 1999.
41. 31a. Van Den Brink M, Van Den Hout WB, Stiggelbout AM, Klein Kranenbarg E, Marijnen CA, Van De Velde CJ, Kievit J; Dutch Colorectal Cancer Group: Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: A study of the Dutch Colorectal Cancer Group. J Clin Oncol 22:244-253, 2004.
42. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW: Prediction of survival in patients with metastases in the spinal column: Results based on a randomized trial of radiotherapy. Cancer 103:320-328, 2005.
43. Yamada Y, Lovelock DM, Yenice KM, Bilsky MH, Hunt MA, Zatcky J, Leibel SA: Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary report. Int J Radiat Oncol Biol Phys 62:53-61, 2005.